
1. General Information
Progynova 2 mg is an oral estrogen medicine containing estradiol valerate. Estradiol valerate is converted into estradiol, a form of estrogen naturally produced by the body. The product is available as a sugar-coated tablet and is a prescription-only medicine in several markets.
For menopause-related treatment, HRT should be individualized according to the patient's symptoms, medical history, age, risk factors, and treatment goals.
2. Product Information
- Brand: Progynova
- Strength: 2 mg
- Active ingredient: Estradiol valerate 2 mg
- Dosage form: Sugar-coated tablet
- Route: Oral
- Drug class: Estrogen / hormone replacement therapy
- ATC code: G03CA03
- Manufacturer: Bayer
- Prescription status: Prescription medicine
Official product information confirms that each Progynova 2 mg tablet contains 2 mg estradiol valerate.
3. Uses of Progynova 2 mg
Progynova may be prescribed for:
- Treatment of symptoms caused by estrogen deficiency during peri- and postmenopause.
- Relief of menopausal symptoms such as hot flushes and sweating.
- Treatment of estrogen deficiency following certain medical procedures affecting ovarian function.
- Prevention of postmenopausal bone loss/osteoporosis in selected women who cannot use other approved osteoporosis medicines.
The exact indication and regimen can vary according to the country's approved product information.
4. Benefits of Progynova 2 mg
When appropriately prescribed, estrogen replacement can help:
- Reduce menopausal vasomotor symptoms such as hot flushes.
- Improve certain symptoms associated with estrogen deficiency.
- Help prevent bone loss after menopause in appropriate patients.
- Replace estrogen when the body is no longer producing sufficient amounts.
The medicine should be used at the lowest effective dose for the shortest appropriate duration for menopausal symptom treatment, under medical supervision.
5. Side Effects of Progynova 2 mg
Possible adverse effects include:
- Headache
- Nausea
- Abdominal discomfort
- Breast tenderness or pain
- Changes in menstrual or vaginal bleeding
- Mood changes
- Fluid retention
- Weight changes
- Skin reactions
Less common but potentially serious risks associated with systemic estrogen therapy include blood clots, stroke, gallbladder problems and certain hormone-sensitive cancers. The individual risk depends on factors such as age, medical history, treatment duration and whether a progestogen is also required.
6. Common Side Effects
Some users may experience:
- Headache
- Breast discomfort
- Nausea
- Abdominal pain or bloating
- Vaginal bleeding or spotting
- Mood changes
- Fluid retention
Patients should consult their doctor if side effects are persistent, troublesome or severe.
7. How to Use Progynova 2 mg
Take Progynova exactly as prescribed by your doctor.
For the UK product information, the usual regimen for appropriate patients is one 2 mg tablet daily, taken consistently at approximately the same time each day. The exact regimen can differ depending on the indication and the patient's circumstances.
- Swallow the tablet with water.
- It may generally be taken with or without food.
- Take it at a consistent time each day.
- Do not change the dose without medical advice.
- If you miss a dose, follow the instructions in your package leaflet or ask your pharmacist/doctor.
8. How Progynova 2 mg Works
Progynova contains estradiol valerate, which acts as a prodrug of estradiol. After administration, it provides estrogen activity similar to the body's natural estradiol. This replaces some of the estrogen that becomes deficient around and after menopause and can reduce symptoms associated with estrogen deficiency. Estrogen also helps reduce postmenopausal bone loss.
9. Safety Advice
Progynova is not suitable for everyone. Important precautions include:
- Do not use it if you have certain estrogen-dependent cancers, unexplained vaginal bleeding, or a current or previous blood-clotting disorder, unless specifically assessed by a doctor.
- Tell your doctor about previous blood clots, stroke, heart disease, liver disease, migraines, high blood pressure, diabetes, gallbladder disease or other significant medical conditions.
- Women who still have a uterus generally need an appropriate progestogen alongside estrogen for part of each cycle to protect the uterine lining.
- Seek urgent medical attention for symptoms suggestive of a blood clot or stroke, such as sudden chest pain, difficulty breathing, or sudden weakness/numbness.
- Regular medical review is important during HRT.
- Progynova should not be used during pregnancy unless specifically directed by a healthcare professional.
Progynova is not a contraceptive.
10. Frequently Asked Questions
Q1. What is Progynova 2 mg used for?
It is an estrogen medicine primarily used for estrogen-deficiency symptoms associated with menopause and, in selected patients, prevention of postmenopausal osteoporosis.
Q2. What is the active ingredient in Progynova?
Each tablet contains 2 mg estradiol valerate.
Q3. Is Progynova a hormone medicine?
Yes. It is an estrogen-containing hormone replacement medicine.
Q4. Can Progynova be taken without a prescription?
It is a prescription medicine in markets such as the UK and Singapore.
Q5. Can Progynova be used by women who still have a uterus?
It can be prescribed, but an appropriate progestogen is generally required for part of the treatment cycle to protect the uterine lining.
Q6. Can Progynova prevent osteoporosis?
It can be used for prevention of postmenopausal osteoporosis in selected women, particularly where other approved options are unsuitable.
Q7. Can I stop Progynova suddenly?
Do not stop or change HRT without discussing it with your healthcare professional.
Q8. Is Progynova the same as Cyclo-Progynova?
No. They are different products. Progynova 2 mg contains estradiol valerate, whereas Cyclo-Progynova contains estradiol valerate plus a progestogen in its combination regimen.
11. Substitutes for Progynova 2 mg
Potential alternatives depend on the active ingredient, indication, dose, route of administration and patient's medical history. Products containing estradiol or estradiol valerate may be considered by a healthcare professional, but they are not automatically interchangeable.
For B2B/export catalog purposes, it is better to describe alternatives as “estradiol/estradiol-valerate HRT alternatives” rather than recommending a specific substitute without a doctor's assessment.
12. SEO Keywords
- Progynova 2 mg Tablet exporter
- Progynova 2 mg Tablet supplier India
- Progynova 2 mg Tablet wholesale supplier
- Progynova 2 mg Tablet pharmaceutical exporter
- Estradiol valerate 2 mg exporter India
- Estradiol valerate tablets supplier
- Progynova 2 mg tablets export from India
- Progynova 2 mg medicine exporter Nagpur
- Progynova 2 mg wholesale pharmaceutical supplier
- Progynova 2 mg HRT tablets supplier
- Progynova 2 mg estrogen tablets exporter
- Progynova 2 mg menopause medicine supplier
- Progynova 2 mg tablets for international buyers
- Progynova 2 mg B2B medicine supplier
- Progynova 2 mg pharmaceutical distributor India
- Progynova 2 mg exporter to USA
- Progynova 2 mg exporter to UK
- Progynova 2 mg exporter to Australia
- Progynova 2 mg exporter to Singapore
- Progynova 2 mg exporter to Canada
- Progynova 2 mg exporter to South Korea
- Progynova 2 mg exporter to UAE
- Estradiol valerate 2 mg wholesale India
- Hormone replacement therapy medicine exporter India
- Estrogen medicine exporter from Nagpur India
- Menopause HRT medicine supplier India
- Pharmaceutical medicine exporter Nagpur India
- Trusted pharma exporter from India
- Phoenix Exim Progynova supplier
- Phoenix Exim pharmaceutical exporter
- Progynova 2 mg international medicine supplier
- Progynova 2 mg bulk pharmaceutical supply
- Estradiol valerate pharmaceutical exporter
- Progynova tablets B2B supplier India
- Progynova 2 mg tablets for pharmaceutical buyers
Keywords







